JAZZ Jazz Pharmaceuticals PE ratio, current and historical analysis
As at Dec 20, 2024, the JAZZ stock has a price-to-earnings ratio of 16.51. This is based on the current EPS of $7.45 and the stock price of $122.97 per share. A decrease of 10% has been recorded in the PE ratio compared to the average of 18.4 of the last four quarters.
JAZZ PE ratio history
The mean historical PE ratio of Jazz Pharmaceuticals over the last ten years is 35.06. The current 16.51 P/E ratio is 53% lower than the historical average. In the past ten years, JAZZ's PE ratio peaked in the Dec 2014 quarter at 167.07, with a price of $163.73 and an EPS of $0.98. The Sep 2019 quarter marked the lowest point at 12.11, with a price of $128.14 and an EPS of $10.58.
Jazz Pharmaceuticals PE ratio by year
Maximum annual increase: 389.8% in 2014
Maximum annual decrease: -84.36% in 2015
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 18.78 | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | 38.56 | 138.17% |
| 2019 | 16.19 | -2.7% |
| 2018 | 16.64 | 0.48% |
| 2017 | 16.56 | -0.36% |
| 2016 | 16.62 | -36.39% |
| 2015 | 26.13 | -84.36% |
| 2014 | 167.07 | 389.8% |
JAZZ average PE ratio chart
The current PE ratio of JAZZ is lower than the 3, 5 and 10-year averages.
JAZZ PE vs peers
In comparison to its peer stock NVS, JAZZ's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVS Novartis AG | 11.25 | $194.15B |
| JAZZ Jazz Pharmaceuticals plc | 16.51 | $7.43B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $25.03B |
| PRGO PERRIGO Co plc | N/A | $3.51B |
| SAGE Sage Therapeutics Inc | N/A | $343.18M |
Frequently asked questions
What is Jazz Pharmaceuticals's PE ratio?
The price to earnings ratio for JAZZ stock as of Dec 20, 2024, stands at 16.51.
What is the 3-year average PE ratio for Jazz Pharmaceuticals (JAZZ)?
The 3-year average price to earnings ratio for JAZZ stock is 36.32.
What is the 5-year average PE ratio for Jazz Pharmaceuticals (JAZZ)?
The 5-year average price to earnings ratio for JAZZ stock is 43.75.
What is the highest PE ratio for JAZZ?
In the last ten years, the Dec 2014 quarter recorded the highest quarterly PE ratio at 167.07.
How does the current PE ratio for JAZZ compare to its historical average?
JAZZ's current price to earnings ratio is 53% below its 10-year historical average.
How is JAZZ's PE ratio calculated (Jazz Pharmaceuticals PE ratio formula)?
The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Dec 20, 2024), Jazz Pharmaceuticals's stock price is $122.97. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $7.45. Therefore, Jazz Pharmaceuticals's PE ratio for today is 16.51. PE RATIO(16.51) = STOCK PRICE($122.97) / TTM EPS($7.45)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.